Asthma control in Brazil: a systematic review

References

• World Health Organization WHO. Asthma Fact Sheet: WHO. 2020 [Internet]. Available from: https://www.who.int/en/news-room/fact-sheets/detail/asthma.
   Google Scholar
• Boulet L-P, Reddel HK, Bateman E, Pedersen S, FitzGerald JM, O'Byrne PM. The global initiative for asthma (GINA): 25 years later. Eur Respir J. 2019;54(2):1900598. doi:10.1183/13993003.00598-2019.
   PubMed Web of Science ®Google Scholar
• Initiative G. Global initiative for asthma: global strategy for asthma management and prevention (Updated 2020). Rev Fr D’Allergologie D’Immunologie Clin. 2020;36(6):685–704.
   Google Scholar
• Soriano JB, Kendrick PJ, Paulson KR, Gupta V, Abrams EM, Adedoyin RA, Adhikari TB, Advani SM, Agrawal A, Ahmadian E, et al. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med. 2020; 8(6):585–596 doi:10.1016/S2213-2600(20)30105-3.
   PubMed Web of Science ®Google Scholar
• PizzichiniI M, Carvalho-Pinto R, Cançado J, Rubin A, Neto A, Cardoso A, et al. Recomendações para o manejo da asma da Sociedade Brasileira de Pneumologia e Tisiologia – 2020. J Bras Pneumol. 2020;46(1):1–16.
   Google Scholar
• Barreto ML, R de C R-S, Malta DC, Oliveira-Campos M, Andreazzi MA, Cruz AA. Prevalência de sintomas de asma entre escolares do Brasil: Pesquisa Nacional em Saúde do Escolar (PeNSE 2012). Rev Bras Epidemiol. 2014;17(SUPPL. 1):106–115. doi:10.1590/1809-4503201400050009.
   PubMedGoogle Scholar
• IV Diretrizes Brasileiras para o Manejo da Asma. J Bras Pneumol. 2006;32(Supl 7):S447–S74.
   PubMedGoogle Scholar
• Cardoso TdA, Roncada C, Silva ERd, Pinto LA, Jones MH, Stein RT, Pitrez PM. The impact of asthma in Brazil: a longitudinal analysis of data from a Brazilian national database system. J Bras Pneumol. 2017;43(3):163–168 doi:10.1590/S1806-37562016000000352.
   PubMed Web of Science ®Google Scholar
• Costa DD, Pitrez PM, Barroso NF, Roncada C. Asthma control in the quality of life levels of asthmatic patients’ caregivers: a systematic review with meta-analysis and meta-regression. J Pediatr (Rio J). 2019; 95(4):401–409. doi:10.1016/j.jped.2018.10.010.
   PubMed Web of Science ®Google Scholar
• Silva N, Carona C, Crespo C, Canavarro MC. Quality of life in pediatric asthma patients and their parents: a meta-analysis on 20 years of research. Expert Rev Pharmacoecon Outcomes Res. 2015; 15(3):499–519. doi:10.1586/14737167.2015.1008459.
   PubMed Web of Science ®Google Scholar
• Bateman ED, Esser D, Chirila C, Fernandez M, Fowler A, Moroni-Zentgraf P, FitzGerald JM. Magnitude of effect of asthma treatments on asthma quality of life questionnaire and asthma control questionnaire scores: systematic review and network meta-analysis. J Allergy Clin Immunol. 2015; 136(4):914–922.
   PubMed Web of Science ®Google Scholar
• Carranza Rosenzweig JR, Edwards L, Lincourt W, Dorinsky P, ZuWallack RL. The relationship between health-related quality of life, lung function and daily symptoms in patients with persistent asthma. Respir Med. 2004;98(12):1157–1165. doi:10.1016/j.rmed.2004.04.001.
   PubMed Web of Science ®Google Scholar
• Haughney J, Price D, Kaplan A, Chrystyn H, Horne R, May N, et al. Achieving asthma control in practice: understanding the reasons for poor control. 2008;
   Google Scholar
• Leite M, Ponte EV, Petroni J, D’Oliveira Junior A, Pizzichini E, Cruz AA. Evaluation of the asthma control questionnaire validated for use in Brazil. J Bras Pneumol Publicacao of da Soc Bras Pneumol e Tisilogia. 2008; 34(10):756–763.
   PubMedGoogle Scholar
• Juniper EF, O′byrne PM, Guyatt G, Ferrie P, King D. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999;14(4):902–907. doi:10.1034/j.1399-3003.1999.14d29.x.
   PubMed Web of Science ®Google Scholar
• Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, Murray JJ, Pendergraft TB. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004;113(1):59–65. doi:10.1016/j.jaci.2003.09.008.
   PubMed Web of Science ®Google Scholar
• Roxo JPF, Ponte EV, Ramos DCB, Pimentel L, D'Oliveira Júnior A, Cruz AA. Portuguese-language version of the asthma control test: validation for use in Brazil. J Bras Pneumol. 2010;36(2):159–166. doi:10.1590/s1806-37132010000200002.
   PubMed Web of Science ®Google Scholar
• Humbert M, Busse W, Hanania NA, Lowe PJ, Canvin J, Erpenbeck VJ, Holgate S. Omalizumab in asthma: an update on recent developments. J Allergy Clin Immunol Pract. 2014;2(5):525–536.e1.
   PubMed Web of Science ®Google Scholar
• BRASIL. Ministério da Saúde. Protocolo Clínico e Diretrizes Terapêuticas – Asma. 2021 [Internet]. Ministério da Saúde. Available from: https://www.gov.br/saude/pt-br/assuntos/protocolos-clinicos-e-diretrizes-terapeuticas-pcdt.
   Google Scholar
• Jenkins C. Barriers to achieving asthma control in adults: evidence for the role of tiotropium in current management strategies. 2019;:423–435.
   Google Scholar
• Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan—a web and mobile app for systematic reviews. Syst Rev. 2016; 5(1):210. doi:10.1186/s13643-016-0384-4.
   PubMedGoogle Scholar
• Sousa AW, Barros Cabral AL, Arruda Martins M, Carvalho CRF. Risk factors for fixed airflow obstruction in children and adolescents with asthma: 4-year follow-up. Pediatr Pulmonol. 2020; 55(3):591–598. doi:10.1002/ppul.24625.
   PubMed Web of Science ®Google Scholar
• Camargos P, Affonso A, Calazans G, Ramalho L, Ribeiro ML, Jentzsch N, Senna S, Stein RT. On-demand intermittent beclomethasone is effective for mild asthma in Brazil. Clin Transl Allergy. 2018;8(1):7. doi:10.1186/s13601-018-0192-0.
   PubMed Web of Science ®Google Scholar
• Jentzsch NS, Silva GCG, Mendes GMS, Brand PLP, Camargos P. Treatment adherence and level of control in moderate persistent asthma in children and adolescents treated with fluticasone and salmeterol. J Pediatr (Rio J). 2019; 95(1):69–75. doi:10.1016/j.jped.2017.10.008.
   PubMed Web of Science ®Google Scholar
• Eller MCN, Vergani KP, Saraiva-Romanholo BM, Antonangelo L, Leone C, Rodrigues JC. Can inflammatory markers in induced sputum be used to detect phenotypes and endotypes of pediatric severe therapy-resistant asthma? Pediatr Pulmonol. 2018;53(9):1208–1217. doi:10.1002/ppul.24075.
   PubMed Web of Science ®Google Scholar
• Jentzsch NS, Camargos P, Sarinho ESC, Bousquet J. Adherence rate to beclomethasone dipropionate and the level of asthma control. Respir Med. 2012; 106(3):338–343.
   PubMed Web of Science ®Google Scholar
• Pitrez PM, de Souza RG, Roncada C, Heinzmann-Filho JP, Santos G, Pinto LA, Jones MH, Stein RT. Impact of omalizumab in children from a middle-income country with severe therapy-resistant asthma: a real-life study. Pediatr Pulmonol. 2017;52(11):1408–1413. doi:10.1002/ppul.23845.
   PubMed Web of Science ®Google Scholar
• Rodrigues AM, Roncada C, Santos G, Heinzmann-Filho JP, de Souza RG, Vargas MHM, Pinto LA, Jones MH, Stein RT, Pitrez PM. Clinical characteristics of children and adolescents with severe therapy-resistant asthma in Brazil. J Bras Pneumol. 2015; 41(4):343–350.
   PubMed Web of Science ®Google Scholar
• Pizzichini MMM, Rocha CC, de Souza Tavares MG, Steidle LJM, Maureci da Silva R, dal Pizzol F, Gibson PG, Pizzichini E. How does the GINA definition of control correlate with quality of life and sputum cellularity? ERJ Open Res. 2019;5(1):00146-2018. doi:10.1183/23120541.00146-2018.
   PubMedGoogle Scholar
• Emilio CC, Mingotti CFB, Fiorin PR, Lima LA, Muniz RL, Bigotto LH. Is a low level of education a limiting factor for asthma control in a population with access to pulmonologists and to treatment? J Bras Pneumol. 2019;45(1)
   PubMed Web of Science ®Google Scholar
• Ponte EV, Lima A, Almeida PCA, de Jesus JPV, Lima VB, Scichilone N, Souza-Machado A, Cruz ÁA. Age is associated with asthma phenotypes. Respirology. 2017;22(8):1558–1563. doi:10.1111/resp.13102.
   PubMed Web of Science ®Google Scholar
• Almeida PCA, Ponte EV, Souza-Machado A, Cruz AA. Longitudinal trends in clinical characteristics and lung function of patients with severe asthma under treatment in Brazil. BMC Pulm Med. 2016;16(1):141. doi:10.1186/s12890-016-0302-5.
   PubMed Web of Science ®Google Scholar
• Antilla M, Castro F, Cruz Á, Rubin A, Rosário N, Stelmach R. Efficacy and safety of the single-capsule combination of fluticasone/formoterol in patients with persistent asthma: a non-inferiority trial. J Bras Pneumol. 2014;40(6):599–608.
   PubMed Web of Science ®Google Scholar
• de Carvalho-Pinto RM, Cukier A, Angelini L, Antonangelo L, Mauad T, Dolhnikoff M, Rabe KF, Stelmach R. Clinical characteristics and possible phenotypes of an adult severe asthma population. Respir Med. 2012;106(1):47–56
   PubMed Web of Science ®Google Scholar
• Lima-Matos A, Ponte EV, de Jesus JPV, Almeida PCA, Lima VB, Kwon N, Riley J, de Mello LM, Cruz ÁA. Eosinophilic asthma, according to a blood eosinophil criterion, is associated with disease severity and lack of control among underprivileged urban Brazilians. Respir Med. 2018;145:95–100.
   PubMed Web of Science ®Google Scholar
• Athanazio R, Carvalho-Pinto R, Fernandes FLA, Rached S, Rabe K, Cukier A, Stelmach R. Can severe asthmatic patients achieve asthma control? A systematic approach in patients with difficult to control asthma followed in a specialized clinic. BMC Pulm Med. 2016;16(1):153. doi:10.1186/s12890-016-0314-1.
   PubMed Web of Science ®Google Scholar
• Souza DS, Noblat L de ACB, Santos P de M. Factors associated with quality of life in patients with severe asthma: the impact of pharmacotherapy. J Bras Pneumol. 2015;41(6):496–501. doi:10.1590/s1806-37562015000004545.
   PubMed Web of Science ®Google Scholar
• Souza-Machado A, Santos PM, Cruz ÁA. Adherence to treatment in severe asthma. World Allergy Organ J. 2010;3(3):48–52. doi:10.1097/WOX.0b013e3181d25e8e.
   PubMedGoogle Scholar
• Ponte EV, Stelmach R, Franco R, Souza-Machado C, Souza-Machado A, Cruz AA. Age is not associated with hospital admission or uncontrolled symptoms of asthma if proper treatment is offered. Int Arch Allergy Immunol. 2014;165(1):61–67. doi:10.1159/000367924.
   PubMed Web of Science ®Google Scholar
• Ponte EV, Souza-Machado A, Souza-Machado C, Franco R, Cruz AA. Atopy is not associated with poor control of asthma. J Asthma. 2012;49(10):1021–1026. doi:10.3109/02770903.2012.733989.
   PubMed Web of Science ®Google Scholar
• Cukier A, Jacob CMA, Rosario Filho NA, Fiterman J, Vianna EO, Hetzel JL, Neis MA, Fiss E, Castro FFM, Fernandes ALG, AIR Brazilian Study Group, et al. Fluticasone/formoterol dry powder versus budesonide/formoterol in adults and adolescents with uncontrolled or partly controlled asthma. Respir Med. 2013;107(9):1330–1338. doi:10.1016/j.rmed.2013.06.018.
   PubMed Web of Science ®Google Scholar
• Schor D, Rizzo JÂ, Medeiros D, Dela Bianca AC, Silva AR, Nunes C, Morais-Almeida M, Sarinho E. Home-made spacer as an auxiliary device in administration of beclomethasone via pressurized metered dose inhaler for asthma control. A randomized controlled pragmatic trial. Respir Med. 2017 May;126:52–58. doi:10.1016/j.rmed.2017.03.017.
   PubMed Web of Science ®Google Scholar
• Rubin A, Souza-Machado A, Andradre-Lima M, Ferreira F, Honda A, Matozo TM, On behalf of the QUALITX Study Investigators Effect of omalizumab as add-on therapy on asthma-related quality of life in severe allergic asthma: a Brazilian study (QUALITX). J Asthma. 2012;49(3):288–293. doi:10.3109/02770903.2012.660297.
   PubMed Web of Science ®Google Scholar
• Serpa FS, Piana MP, Neto B, Campinhos F, Silveira FL, da MG, Chiabai J. Effectiveness of anti-IgE therapy for asthma control. Brazilian J Allergy Immunol. 2014;2(4)
   Google Scholar
• Caminati M, Vaia R, Furci F. Uncontrolled asthma: Unmet needs in the management of patients uncontrolled asthma: Still a challenge. 2021;:457–466.
   Google Scholar
• To T, Stanojevic S, Moores G, Gershon AS, Bateman ED, Cruz AA, Boulet L-P. Global asthma prevalence in adults: Findings from the cross-sectional world health survey. BMC Public Health. 2012;12(1) doi:10.1186/1471-2458-12-204.
   Web of Science ®Google Scholar
• BRASIL. Ministério da Saúde Omalizumabe para o tratamento de asma alérgica grave não controlada apesar do uso de corticoide inalatório associado a um beta-2 agonista de longa ação. 2019;110
   Google Scholar
• Macdonald KM, Kavati A, Ortiz B, Alhossan A, Lee CS, Abraham I. Short- and long-term real-world effectiveness of omalizumab in severe allergic asthma: systematic review of 42 studies published 2008-2018. Expert Rev Clin Immunol. 2019;15(5):553–569. doi:10.1080/1744666X.2019.1574571.
   PubMed Web of Science ®Google Scholar
• Holgate ST, Wenzel S, Postma DS, Weiss ST, Renz H, Sly PD. The 2015 global strategy for asthma management and prevention by the global initiative for. Nat Rev Dis Prim. 2015;1:1–22.
   Google Scholar
• Bateman ED, Frith LF, Braunstein GL. Achieving guideline-based asthma control: does the patient benefit? Eur Respir J. 2002; 20(3):588–596. doi:10.1183/09031936.02.00294702.
   PubMed Web of Science ®Google Scholar
• Barnes CB, Ulrik CS. Asthma and adherence to inhaled corticosteroids: current status and future perspectives. Respir Care. 2015; 60(3):455–468. doi:10.4187/respcare.03200.
   PubMed Web of Science ®Google Scholar